Concepedia

Julie Jones

JJ

Statistics

Publications

15

Citations

2.4K

H-Index

13

Active since

1974

Affiliations

Novartis (Switzerland)(Current)

Novartis Institutes for BioMedical Research

Medical University of Vienna

University of Edinburgh

Roslin Institute

Julie Jones is an author at Novartis (Switzerland) specializing in medicine, health sciences, and covid-19.

ORCID

Top concepts

Publications per year

1974–2023

15

Publications

15

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi et al. · The Lancet · 2021 · 555 citations · Full text

, , +7

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 516 citations · Full text

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2022 · 382 citations · Full text

, , +3

Phase I/II Trial of StemRegenin-1 Expanded Umbilical Cord Blood Hematopoietic Stem Cells Supports Testing as a Stand-Alone Graft

John E. Wagner, Claudio G. Brunstein, Anthony E. Boitano et al. · Cell stem cell · 2015 · 326 citations · Full text

, , +12

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 289 citations · Full text

1–5 of 15